Methapharm Inc. announces participation in Triumvira Immunologics Inc. Convertible Debenture

Friday, November 9, 2018 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

ONTARIO, Canada, Nov. 9, 2018 /PRNewswire-iReach/ -- Methapharm is pleased to announce that it has participated in a Private

Placement of a Convertible Debenture of Triumvira Immunologics Inc.

About Methapharm

Methapharm is a privately held specialty pharmaceutical company that focuses on the acquisition, licensing, and promotion of healthcare products

in North America.   Methapharm markets its own proprietary products, and partners with global companies to promote products in the USA and Canada.  This investment accords with Methapharm's strategy to acquire marketed products, as well as invest in promising early-stage opportunities.

About Triumvira Immunologics

Triumvira Immunologics, Inc. is an immuno-oncology company, developing a novel platform for engineering T cells to attack both liquid and solid tumors. Triumvira's proprietary T Cell-Antigen Coupler (TAC) co-opts the natural T Cell receptor biology and functions. This approach operates through the native T cell receptor, in turn optimizing selectivity and signaling, and has demonstrated superiority over CAR-T in pre-clinical studies. Led by a management team with decades of drug development expertise, Triumvira's pipeline includes multiple oncology trials slated to enter the clinic in 2019.

Media Contact: Chris Calenti, Methapharm Inc., 5197513602, ccalenti@methapharm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE Methapharm Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store